Cargando…
Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis
The process of drug discovery and drug development consumes billions of dollars to bring a new drug to the market. Drug development is time consuming and sometimes, the failure rates are high. Thus, the pharmaceutical industry is looking for a better option for new drug discovery. Drug repositioning...
Autores principales: | Prakash, Annamneedi Venkata, Park, Jun Woo, Seong, Ju-Won, Kang, Tae Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216745/ https://www.ncbi.nlm.nih.gov/pubmed/32133828 http://dx.doi.org/10.4062/biomolther.2020.001 |
Ejemplares similares
-
Potential Natural Biomolecules Targeting JAK/STAT/SOCS Signaling in the Management of Atopic Dermatitis
por: Kopalli, Spandana Rajendra, et al.
Publicado: (2022) -
Integrative transcriptome-wide analysis of atopic dermatitis for drug repositioning
por: Song, Jaeseung, et al.
Publicado: (2022) -
TSLP Polymorphisms in Atopic Dermatitis and Atopic March in Koreans
por: Heo, Won Il, et al.
Publicado: (2018) -
NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023) -
Repositioning of the antipsychotic drug TFP for sepsis treatment
por: Park, Jung Hwa, et al.
Publicado: (2019)